Bioptik Technology Incorporation (TPEX:4161)

Market Cap	1.38B -14.4%
Revenue (ttm)	912.86M +10.8%
Net Income	108.52M +65.8%
EPS	1.84 +66.4%
Shares Out	59.81M
PE Ratio	12.50
Forward PE	n/a
Dividend	0.70 (3.08%)
Ex-Dividend Date	Jul 16, 2026

Volume	2,850
Open	23.10
Previous Close	23.00
Day's Range	23.10 - 23.10
52-Week Range	21.20 - 30.50
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About TPEX:4161

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats. It also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscree...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4161

Financial Performance

In 2025, TPEX:4161's revenue was 837.19 million, a decrease of -3.25% compared to the previous year's 865.34 million. Earnings were 71.19 million, a decrease of -23.92%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 26, 2026

Data Sources Report a data error